Indegene Limited (INDGN)
Transcript of the Q2 FY27 Earnings Call
AI summary
- Q2 FY27 revenue INR11,223 million (+39.5% y-y, +5.6% q-q); EBITDA INR1,873 million (+32% y-y) at 16.7% margin
- Wage hikes impacted margins by ~150 bps; productivity and FX gains offset
- 9 new deals won including $5M+ and $3-5M deals; Tectonic model expanding to Canada
- BioPharm acquisition integration progressing; $1.5M cost synergies reinvested
- Outlook: organic growth better than FY26; quarterly EBITDA margin target 19%+ by Q4
- Enterprise Commercial growth strong; Medical segment stable; Others segment uplift from Clinical deal
- Outcome-based contracts increasing; $10M ACV deal ramping in Q4
- Net DSO 69 days; cash & investments INR13,896 million
- Multiple analyst queries on Tectonic ramp-up, GenAI AOR, and margin trajectory in H2FY27
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 INDGN — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add INDGN to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Indegene Limited
Important.
The summary above is generated automatically from Indegene Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.